Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

605
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

214
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
214

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased Risk of Myositis-Specific and Myositis-Associated Autoantibodies After COVID-19 Pandemic and Vaccination: A Spanish Multicenter Collaborative Study.

Biomedicines·2025
Same author

Systemic Inflammation in Oncologic Patients Undergoing Systemic Treatment and Receiving Whey Protein-Based Nutritional Support.

International journal of molecular sciences·2024
Same author

Nutritional Support Reduces Circulating Cytokines in Patients with Heart Failure.

Nutrients·2024
Same author

Corrigendum to "Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus - A proposal from an expert panel" [Autoimmunity Reviews, Volume 22, Issue 12, December 2023, 103479].

Autoimmunity reviews·2024
Same author

Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus - A proposal from an expert panel.

Autoimmunity reviews·2023
Same author

Longitudinal study of patients with discrepant results in CLIFT and a solid-phase dsDNA antibody assay: does a gold standard dsDNA assay exist?

Lupus science & medicine·2023

Related Experiment Video

Updated: Jul 25, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Improved gestational diabetes screening protocol.

Miguel Calero Rojas1, Aurora Jurado Roger2, Marta Gutiérrez Grúa1

  • 1Obstetrics and Gynaecology Unit, Hospital Infanta Margarita, Cabra, Spain.

Advances in Laboratory Medicine
|June 26, 2023
PubMed
Summary

The Glucose Challenge Test (GCT) demonstrates superior diagnostic validity for screening gestational diabetes mellitus (GDM) compared to HbA1c testing. Utilizing higher GCT cut-offs can significantly reduce the need for oral glucose overload tests in pregnant women.

Keywords:
adverse eventsgestational diabetesglucose challenge testglycated haemoglobinscreening

More Related Videos

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

705
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Related Experiment Videos

Last Updated: Jul 25, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K
Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

705
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Area of Science:

  • Obstetrics and Gynecology
  • Endocrinology
  • Clinical Diagnostics

Background:

  • Gestational diabetes mellitus (GDM) screening aims to identify pregnant women at risk.
  • Current diagnostic methods can be invasive or less accurate.
  • There is a need for more comfortable and effective GDM screening approaches.

Purpose of the Study:

  • To evaluate the diagnostic validity of two screening methods for GDM.
  • To compare the Glucose Challenge Test (GCT) with HbA1c testing for GDM diagnosis.
  • To assess an algorithm combining GCT and HbA1c for improved GDM screening.

Main Methods:

  • A prospective diagnostic validation study involving 2007 pregnant women.
  • Participants were categorized into high-risk and low-risk groups based on GDM risk factors.
  • Comparison of GCT, HbA1c testing, and a combined algorithm against the standard oral glucose overload test.

Main Results:

  • In low-risk women, GCT showed higher diagnostic accuracy (AUC 0.953) than HbA1c (AUC 0.688).
  • In high-risk women, GCT consistently outperformed HbA1c and the combined algorithm across different weeks of gestation (e.g., 13th week GCT AUC 0.882).
  • Optimal GCT cut-offs were identified, often higher than current recommendations, demonstrating superior validity.

Conclusions:

  • A GDM screening strategy starting with GCT using elevated cut-offs offers the best diagnostic validity.
  • This approach could potentially avoid 55.6% of oral glucose overload tests in low-risk and 13.7% in high-risk pregnancies.
  • Implementing higher GCT cut-offs represents a more efficient and less burdensome screening method for GDM.